Inventor · disambiguated record
Albert Sun-Chi Chan
Also filed as: CHAN ALBERT S · CHAN ALBERT S C · CHAN ALBERT S K · CHAN ALBERT SUN-CHI
44 granted patents·15 pending applications·378 citations·filing 1981–2016
97Inventor score
Files withUNIV HONG KONG BAPTIST18UNIV HONG KONG POLYTECHNIC13MONSANTO CO12UNIV HONG KONG BAPTIST UNIV7CHAN ALBERT S2
Top patents by PatentIndex Score
59 records- 0193US8344007B2Water-soluble polymer-based cantharimides as potentially selective anti-tumor agentsUNIV HONG KONG POLYTECHNIC·Filed 2009·Granted Jan 1, 2013·60 cites·19 claims
- 0283US9493419B2Quinoline derivatives as anti-cancer agentsTANG JOHNNY CHEUK-ON·Filed 2011·Granted Nov 15, 2016·9 cites·22 claims
- 0383US5961955ARadioprotectant for peptides labeled with radioisotopeCOULTER PHARM INC·Filed 1997·Granted Oct 5, 1999·50 cites·81 claims
- 0483US4870208AAsymmetric hydrogenolysis of epoxidesMONSANTO CO·Filed 1988·Granted Sep 26, 1989·20 cites·10 claims
- 0581US9321730B2Method of making and administering quinoline derivatives as anti-cancer agentsCHAN ALBERT SUN-CHI·Filed 2007·Granted Apr 26, 2016·9 cites·20 claims
- 0681US4405814AHydroformylation of formaldehyde with rhodium catalystsMONSANTO CO·Filed 1981·Granted Sep 20, 1983·17 cites·11 claims
- 0777US5990318ASoluble polyester-supported chiral phosphinesUNIV HONG KONG POLYTECHNIC·Filed 1998·Granted Nov 23, 1999·30 cites·34 claims
- 0877US4477685AHydroformylation process to prepare glycolaldehydesMONSANTO CO·Filed 1982·Granted Oct 16, 1984·12 cites·17 claims
- 0975US6338835B1Radioprotectant for peptides labeled with radioisotopeCOULTER PHARM INC·Filed 1999·Granted Jan 15, 2002·39 cites·23 claims
- 1074US5144050ARuthenium(II)-BINAP diketonate complexesMONSANTO CO·Filed 1991·Granted Sep 1, 1992·15 cites·10 claims
- 1171US7592487B2Chiral tertiary aminoalkylnaphtholsUNIV HONG KONG POLYTECHNIC·Filed 2005·Granted Sep 22, 2009·2 cites·21 claims
- 1270US4678662APyrophosphate coating process for calcium carbonate dental abrasivesMONSANTO CO·Filed 1985·Granted Jul 7, 1987·36 cites·20 claims
- 1368US9044502B2Chinese medicinal formulation for treating inflammatory bowel disease and the preparation thereofUNIV HONG KONG BAPTIST·Filed 2013·Granted Jun 2, 2015·2 cites·19 claims
- 1463US4633015AProduction of adipic acid from 1,4-disubstituted-2-buteneMONSANTO CO·Filed 1984·Granted Dec 30, 1986·6 cites·19 claims
- 1563US4611082AProduction of hex-3-enedioate esters from 1,4 dialkoxy butenesMONSANTO CO·Filed 1984·Granted Sep 9, 1986·6 cites·17 claims
- 1662US5919981AChiral aminophosphinesUNIV HONG KONG POLYTECHNIC·Filed 1997·Granted Jul 6, 1999·9 cites·7 claims
- 1761US9339488B2Anti-cervical cancer compound and method of use thereofUNIV HONG KONG BAPTIST·Filed 2014·Granted May 17, 2016·0 cites·4 claims
- 1860US9655913B2Anti-esophageal cancer compound and method of use thereofUNIV HONG KONG BAPTIST UNIV·Filed 2016·Granted May 23, 2017·0 cites·4 claims
- 1960US9408811B2Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancerUNIV HONG KONG BAPTIST UNIV·Filed 2014·Granted Aug 9, 2016·0 cites·8 claims
- 2059US5886182AChiral pyridylphosphines and their application in asymmetric catalytic hydrogenation of 2-arylpropenoic acidsUNIV HONG KONG POLYTECHNIC·Filed 1997·Granted Mar 23, 1999·10 cites·6 claims
- 2159US5233084AMethod for preparing α-arylpropionic acidsMONSANTO CO·Filed 1990·Granted Aug 3, 1993·7 cites·15 claims
- 2258US9775857B2Lignans isolated from Lasia spinosa (L.) ThwaitUNIV HONG KONG BAPTIST UNIV·Filed 2016·Granted Oct 3, 2017·0 cites·7 claims
- 2358US4994607AAsymmetric catalytic hydrogenation of α-arylpropenic acidsMONSANTO CO·Filed 1989·Granted Feb 19, 1991·5 cites·5 claims
- 2457US7713900B2Chiral tertiary aminoalkylnaphtholsUNIV HONG KONG POLYTECHNIC·Filed 2008·Granted May 11, 2010·0 cites·9 claims
- 2555US5202473ARuthenium-binap asymmetric hydrogenation catalystMONSANTO CO·Filed 1992·Granted Apr 13, 1993·13 cites·6 claims
- 2654US5202474AAsymmetric catalytic hydrogenation of α-arylpropenoic acidsMONSANTO CO·Filed 1990·Granted Apr 13, 1993·5 cites·7 claims
- 2753US7674900B2Chiral tertiary aminoalkylnaphtholsUNIV HONG KONG POLYTECHNIC·Filed 2005·Granted Mar 9, 2010·0 cites·6 claims
- 2853US2014235877A1Compounds, methods of preparation and use thereof for treating cancerUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 2952US2006045927A1Herbal formulations for modulating blood lipidsYANG DAJIAN·Filed 2004·Application pending·0 cites
- 3051US2014194529A1Usage of natural compound for treating inflammation and cancerUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 3150US9120816B2Oxanorbornadiene derivatives and their anticancer activitiesUNIV HONG KONG BAPTIST·Filed 2013·Granted Sep 1, 2015·0 cites·16 claims
- 3250US2013210906A1Compounds, methods of preparation and use thereof for treating cancerUNIV HONG KONG BAPTIST·Filed 2013·Application pending·0 cites
- 3349US6680385B2Catalytic preparation of aryl methyl ketones using a molecular oxygen-containing gas as the oxidantUNIV HONG KONG POLYTECHNIC·Filed 2002·Granted Jan 20, 2004·2 cites·30 claims
- 3449US2014194528A1Usage of sodium houttuyfonate on inhibiting idiopathic pulmonary fibrosis and bleomycin induced pulmonary fibrosisUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 3548US2014194530A1Usage of oblongifolin c, a natural compound from garcinia yunnanensis hu, on treating cancer as metastasis inhibitor and autophagic flux inhibitorUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 3647US8835658B2Asymmetric synthesis of norcantharidin analougus by alkynylation of oxabenzonorbornadienes and their anticancer activitiesUNIV HONG KONG BAPTIST·Filed 2012·Granted Sep 16, 2014·0 cites·6 claims
- 3747US2015011646A1Usage of guttiferone k, a natural compound from garcinia yunnanensis hu on treating high metastatic esophageal cancerUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 3846US7718831B2Method for asymmetric hydrosilylation of ketonesUNIV HONG KONG POLYTECHNIC·Filed 2006·Granted May 18, 2010·0 cites·19 claims
- 3945US8652540B2Method of using rhein for treating fibrotic conditions and tumorsUNIV HONG KONG BAPTIST·Filed 2013·Granted Feb 18, 2014·0 cites·5 claims
- 4045US2013344174A1Bioactive Fractions and Compounds from Polygonum genus, their Use in Anti-diarrhea and the Method of PreparationUNIV HONG KONG BAPTIST·Filed 2013·Application pending·0 cites
- 4145US2014200265A1Usage of 1,3,5,7-tetrahydroxy-8-isoprenylxanthone for treating inflammationUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 4243US9260466B2Use of a flavanol glycoside for suppressing activation of stellate cellsUNIV HONG KONG BAPTIST·Filed 2013·Granted Feb 16, 2016·0 cites·6 claims
- 4343US2014194499A1Polyprenylated Benzoylphloroglucinols With Anticancer ActivityUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 4443US2014194498A1Polyisoprenylated tetracyclic xanthone with anticancer activityUNIV HONG KONG BAPTIST·Filed 2014·Application pending·0 cites
- 4543US2013210907A1Method for preventing or treating enterochromaffin cell hyperplasia-related diseases by quercetin administrationUNIV HONG KONG BAPTIST·Filed 2013·Application pending·0 cites
- 4642US7612239B2Method for asymmetric alkynylation of alpha-imino estersUNIV HONG KONG POLYTECHNIC·Filed 2006·Granted Nov 3, 2009·0 cites·9 claims
- 4741US7094725B2Biphenyldiphosphine compoundsUNIV HONG KONG POLYTECHNIC·Filed 2004·Granted Aug 22, 2006·0 cites·35 claims
- 4840US5198561ARuthenium-BINAP asymmetric hydrogenation catalystMONSANTO CO·Filed 1991·Granted Mar 30, 1993·5 cites·10 claims
- 4940US2017035824A1Usage of oblongifolin c, a natural compound from garcinia yunnanensis hu, on treating cancer as metastasis inhibitor and autophagic flux inhibitorUNIV HONG KONG BAPTIST UNIV·Filed 2016·Application pending·0 cites
- 5039US2006084615A1Puerarin derivatives and their medical usesCHAN ALBERT S·Filed 2004·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Albert Sun-Chi Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →